It is striking that diseases that are strongly auto-antibody mediated, such as most rheumatological diseases, are affected by alterations in PTPN22 and PTPN2, whereas T cell driven diseases such as MS and psoriasis lean more heavily towards changes in other PTPs such as CD45 and SHP-1. The gene discussed is PTPRC; the disease is psoriasis.